Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and DepressionRobert A. Hodgson, John C. Hunter, A Forlani et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 149
CNS Anticancer Drug Discovery and Development Conference White PaperVictor A. Levin, Russell C. Petter, Peter J. Tonge et al.|Neuro-Oncology|2015Cited by 45